Your browser doesn't support javascript.
loading
Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time
Mata Fernández, Cristina; Gutierrez Carrasco, Nacho; Ribelles, Antonio Juan; Hindi Muñiz, Nadia; Estival González, Anna; San Simón, Alba Rubio; Castillo Portellano, Lucía; Ruiz Medina, Sofía; Valverde Morales, Claudia.
Affiliation
  • Mata Fernández, Cristina; Hospital Universitario Materno Infantil Gregorio Marañón. Pediatric and Adolescent Oncohematology Unit. Madrid. Spain
  • Gutierrez Carrasco, Nacho; Hospital Universitario Virgen del Rocío. Sevilla. Spain
  • Ribelles, Antonio Juan; Hospital Universitario y Politécnico La Fe. Valencia. Spain
  • Hindi Muñiz, Nadia; Hospital Fundación Jiménez Díaz. Madrid. Spain
  • Estival González, Anna; Instituto Catalán de Oncología, ICO. Badalona. Spain
  • San Simón, Alba Rubio; Hospital Infantil Niño Jesús. Madrid. Spain
  • Castillo Portellano, Lucía; Hospital Virgen de las Nieves. Granada. Spain
  • Ruiz Medina, Sofía; Hospital Universitario Virgen de la Victoria. Málaga. Spain
  • Valverde Morales, Claudia; Hospital Universitario Vall d´Hebron. Barcelona. Spain
Clin. transl. oncol. (Print) ; 24(12): 2475-2479, dec. 2022.
Article in English | IBECS | ID: ibc-216093
Responsible library: ES1.1
Localization: ES15.1 - BNCS
ABSTRACT
Introduction We aimed to analyse health care services for adolescents and young adults (AYA) with sarcomas in Spain. Methods A survey was sent to all Spanish cancer centres, including questions about demographic, facilities, and treatment strategies for AYAs with sarcomas in the last 2 years. Results Thirty-five units participated in the survey, 17 paediatric and 15 adult units. There were three specialized AYA units. First line regimen varied depending on whether the treating unit was paediatric or not, for osteosarcomas, rhabdomyosarcomas, and non-rhabdomyosarcomas. By contrast, 91.4% of Ewing sarcomas were treated according to EE2012. In the relapse setting, differences between units were higher in all tumours. Additionally, 48% of the units reported not having trials for this population. Conclusion There are major differences in the treatment of AYAs with sarcomas between adult and paediatric units. Enormous efforts are needed to homogenize treatments and increase the access to innovation. (AU)
Subject(s)

Search on Google
Collection: National databases / Spain Database: IBECS Main subject: Bone Neoplasms / Osteosarcoma / Health Care Surveys Limits: Adolescent / Humans Country/Region as subject: Europa Language: English Journal: Clin. transl. oncol. (Print) Year: 2022 Document type: Article Institution/Affiliation country: Hospital Fundación Jiménez Díaz/Spain / Hospital Infantil Niño Jesús/Spain / Hospital Universitario Materno Infantil Gregorio Marañón/Spain / Hospital Universitario Vall d´Hebron/Spain / Hospital Universitario Virgen de la Victoria/Spain / Hospital Universitario Virgen del Rocío/Spain / Hospital Universitario y Politécnico La Fe/Spain / Hospital Virgen de las Nieves/Spain / Instituto Catalán de Oncología, ICO/Spain
Search on Google
Collection: National databases / Spain Database: IBECS Main subject: Bone Neoplasms / Osteosarcoma / Health Care Surveys Limits: Adolescent / Humans Country/Region as subject: Europa Language: English Journal: Clin. transl. oncol. (Print) Year: 2022 Document type: Article Institution/Affiliation country: Hospital Fundación Jiménez Díaz/Spain / Hospital Infantil Niño Jesús/Spain / Hospital Universitario Materno Infantil Gregorio Marañón/Spain / Hospital Universitario Vall d´Hebron/Spain / Hospital Universitario Virgen de la Victoria/Spain / Hospital Universitario Virgen del Rocío/Spain / Hospital Universitario y Politécnico La Fe/Spain / Hospital Virgen de las Nieves/Spain / Instituto Catalán de Oncología, ICO/Spain
...